Analysts Set The Clorox Company (NYSE:CLX) PT at $103.73

The Clorox Company (NYSE:CLX) has been given an average rating of “Reduce” by the seventeen research firms that are presently covering the stock, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a sell recommendation, eleven have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $103.40.

A number of research analysts have recently issued reports on CLX shares. Morgan Stanley dropped their price target on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research report on Friday, May 1st. Rothschild & Co Redburn set a $117.00 price objective on shares of Clorox in a research note on Friday, February 13th. JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, May 1st. Evercore reiterated an “underperform” rating and issued a $110.00 price objective on shares of Clorox in a research note on Friday, May 1st. Finally, The Goldman Sachs Group reiterated a “sell” rating and issued a $83.00 price objective on shares of Clorox in a research note on Friday, May 1st.

Clorox Stock Down 0.2%

Shares of NYSE CLX opened at $94.97 on Friday. The company has a market capitalization of $11.48 billion, a P/E ratio of 15.42, a price-to-earnings-growth ratio of 0.49 and a beta of 0.59. Clorox has a 52-week low of $84.70 and a 52-week high of $132.03. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The company’s 50 day moving average price is $99.99 and its 200-day moving average price is $106.29.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company’s revenue for the quarter was up .1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities analysts forecast that Clorox will post 5.61 earnings per share for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 8th. Stockholders of record on Wednesday, April 22nd were paid a $1.24 dividend. The ex-dividend date was Wednesday, April 22nd. This represents a $4.96 annualized dividend and a dividend yield of 5.2%. Clorox’s payout ratio is currently 80.52%.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber acquired 5,000 shares of the stock in a transaction dated Tuesday, May 5th. The stock was bought at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the purchase, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.63% of the stock is owned by corporate insiders.

Institutional Trading of Clorox

Several hedge funds have recently modified their holdings of the stock. Norges Bank bought a new stake in Clorox during the 4th quarter valued at $135,735,000. Van ECK Associates Corp increased its stake in Clorox by 93.9% during the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock valued at $334,139,000 after purchasing an additional 1,312,471 shares in the last quarter. Invesco Ltd. increased its stake in Clorox by 22.1% during the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after purchasing an additional 884,751 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its stake in Clorox by 6,907.9% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock valued at $75,593,000 after purchasing an additional 739,005 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC bought a new stake in Clorox during the 2nd quarter valued at $71,856,000. Institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.